Evidence map›Paper›PMID 35871061›Full record

ArticleCell death & disease2022

UPF1/circRPPH1/ATF3 feedback loop promotes the malignant phenotype and stemness of GSCs.

Jinkun Xu, Guoqing Zhang, Jinpeng Hu, Hao Li, Junshuang Zhao, Shengliang Zong, Zhengting Guo, Yang Jiang, Zhitao Jing

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. The Glioblastoma CircularRNAome.International journal of molecular sciences · 2023
    Review
  17. Review
  18. C-Fos-activated circRPPH1 contributes to glioma stemness.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jinkun XuDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Guoqing ZhangDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Jinpeng HuDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Hao LiDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.ORCID 0000-0003-0513-0771
Junshuang ZhaoDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Shengliang ZongDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Zhengting GuoDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China.
Yang JiangDepartment of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. windjy0523@qq.com.
Zhitao JingDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, China. jingzhitao@hotmail.com.ORCID 0000-0002-8915-9039
First Hospital of China Medical University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most lethal type of craniocerebral gliomas. Glioma stem cells (GSCs) are fundamental reasons for the malignancy and recurrence of GBM. Revealing the critical mechanism within GSCs' self-renewal ability is essential. Our study found a novel circular RNA (circRPPH1) that was up-regulated in GSCs and correlated with poor survival. The effect of circRPPH1 on the malignant phenotype and self-renewal of GSCs was detected in vitro and in vivo. Mechanistically, UPF1 can bind to circRPPH1 and maintain its stability. Therefore, more existing circRPPH1 can interact with transcription factor ATF3 to further transcribe UPF1 and Nestin expression. It formed a feedback loop to keep a stable stream for stemness biomarker Nestin to strengthen tumorigenesis of GSCs continually. Besides, ATF3 can activate the TGF-β signaling to drive GSCs for tumorigenesis. Knocking down the expression of circRPPH1 significantly inhibited the proliferation and clonogenicity of GSCs both in vitro and in vivo. The overexpression of circRPPH1 enhanced the self-renewal of GSCs. Our findings suggest that UPF1/circRPPH1/ATF3 maintains the potential self-renewal of GSCs through interacting with RNA-binding protein and activating the TGF-β signal pathway. Breaking the feedback loop against self-renewing GSCs may represent a novel therapeutic target in GBM treatment.

Indexed as

Brain NeoplasmsGlioblastomaGliomaActivating Transcription Factor 3CarcinogenesisCell Line, TumorCell ProliferationCell Transformation, NeoplasticFeedbackHumansNeoplastic Stem CellsNestinPhenotypeRNA HelicasesTrans-ActivatorsTransforming Growth Factor betaActivating Transcription Factor 3ATF3 protein, humanNestinRNA HelicasesTrans-ActivatorsTransforming Growth Factor betaUPF1 protein, human

Identifiers

PMID35871061
PMCPMC9308777
OpenAlexW4286722223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.